W Robert Lee

8PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Biomedical instrumentationAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 08, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

W Robert Lee, James J Dignam, Mahul B Amin

|Feb 22, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.

Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman

|Feb 28, 2023
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415.

David J Carpenter, Joseph K Salama, W Robert Lee

|Dec 29, 2022
The importance of body composition in patients with prostate cancer receiving radiotherapy.

Ryan Fecteau, W Robert Lee

|Oct 06, 2022
Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer.

Edina C Wang, W Robert Lee, Andrew J Armstrong

Pageof 2

Frequent Collaborators

2 joint publications

Andrew J Armstrong

2 joint publications

Howard M Sandler

2 joint publications

Jeff Michalski

2 joint publications

Deborah Watkins Bruner